Elsevier

Virus Research

Volume 111, Issue 1, July 2005, Pages 77-82
Virus Research

Indirect oral immunization of captive vampires, Desmodus rotundus

https://doi.org/10.1016/j.virusres.2005.03.013Get rights and content

Abstract

A vaccinia-rabies glycoprotein recombinant virus (V-RG) vaccine was tested in hematophagous bats (Desmodus rotundus) kept in captivity. The vaccine was applied in a neutral vehicle (Vaseline) spread on the back of one or two vector bats, which were then reintroduced into their groups. Our hypothesis was that, as in the case of vampire bat control by vampiricide paste, the administration of V-RG vaccine through paste to one bat could indirectly protect other bats from the same group. Eight groups were tested. The rabies virus strain used to challenge the bats was isolated from a naturally infected hematophagous bat (Desmodus rotundus). The survival proportion after the virus challenge ranged between 42.8 and 71.4%. The results are encouraging because a significant number of bats that did not receive the vaccine survived the challenge. The vaccine was shown to be safe and immunogenic to hematophagous bats. No adverse effects to vaccinia virus were observed.

Introduction

The use of preventive vaccines against rabies largely contributed to the reduction or local eradication of rabies in domestic animals. Therefore, it would be natural the attempt to vaccinate wild animals. However, the control of rabies in wildlife population, which replaced dogs as reservoirs and vectors of rabies, required other strategies such as the successful oral vaccination of wild mammals in Europe.

Since 1978, several European countries conducted oral rabies vaccination programs for terrestrial wildlife. One of the vaccines used in the field is V-RG, a recombinant vaccinia virus, which expresses the glycoprotein of rabies virus (Kieny et al., 1984). Millions of baits containing V-RG vaccine were distributed in the last decade in Canada, United States, Switzerland, Germany, Belgium and France. Programs of oral vaccination of red foxes (Vulpes vulpes), raccoons (Procyon lotor) and coyotes (Canis latrans) were successful in eliminating rabies from large areas (Brochier et al., 1991, Pastoret et al., 1988, Hanlon et al., 1998, MacInnes et al., 2001).

In countries where progress has been made in terms of human rabies prevention, bats have been responsible by a significant proportion of human infections. In the USA, from 1990 to 2000, 30 of the 32 human rabies cases were associated with insectivorous bat rabies virus variants (CDC, 2000).

In Latin America, the hematophagous bat (Desmodus rotundus) is one of the main reservoirs of rabies virus and causing heavy economic losses in livestock annually. Currently, the control of rabies transmitted by Desmodus rotundus is performed by bat population reduction using anticoagulants applied on the backs of targeted vector bats (Linhart et al., 1972). Due to their habit of hygiene, the anticoagulant agent is spread among the colony, killing between 10 and 20 bats per vector bat (Greenhall, 1965). The use of anticoagulants is still very controversial. Some investigators have proved them to be successful (Arellano-Sota, 1988) while for others the anticoagulants have been shown to produce moderate success. Yet, anticoagulants are not an effective method to stop the spread of disease (Jackson, 2002). Another control strategy, although much more expensive, is vaccination of cattle.

Analysis of animal rabies in Brazilian samples by monoclonal antibodies and molecular sequencing showed that dogs and vampire bats are the main vector reservoirs (Ito et al., 2001, Favoreto et al., 2002). The virus variant 3, characteristic of vampire bats, was isolated from 100% of cattle, horses and vampire bat samples (111) taken and in 58.3% of samples (35) of non-vampire bats, showing the importance of Desmodus rotundus as a reservoir of rabies in Brazil.

In Brazil, the number of human rabies cases has been 20–30 per year since 1994. Bats are the second most frequently identified vector-related to human rabies cases. Bat bites on humans have been reported in Brazil always associate to enviromental modifications in bats habitats (Batista da Costa et al., 1993, Scheneider et al., 2001). Recently, in two Brazilian villages of the North country, 21 people bitten by a vampire bat died of rabies. The antigenic analysis of samples from this outbreak identified the variant 3 virus. As for animal rabies in the period between 1994 and 2003, 20,590 cases of rabies in cattle, 2314 in horses and 676 in hematophagous bats and non-hematophagous bats were reported (Health Ministry from Brazil, 2004).

The objective of this study is to assess the immunogenicity of a recombinant rabies vaccine (V-RG) applied in a neutral vehicle spread on the back of hematogphagous vector bats (Desmodus rotundus), kept in captivity. Our hypothesis is that the behavior of the vampire bat (self-hygiene and intense corporal contact to each other in the colony) allows the paste mixed with an oral vaccine applied on the back of one bat to indirectly protect other bats from the same colony. This strategy may represent an alternative control method to the anticoagulant, vampiricide paste, which is decimating the population of Desmodus rotundus.

To test this we carried out a set of experiments in which we applied an oral vaccine mixed with neutral Vaseline paste on the back of one bat that was then allowed to live with 6–9 other non-pasted bats in groups distributed into special cages designed to this end. All the bats of all groups were then challenged with intramuscular injections of live rabies virus and the proportion of survivals was annotated.

Section snippets

Captivity

The bats (Desmodus rotundus) used in this experiment were adults (males and females), maintained in cages designed specially for rabies experimental purposes, at the School of Medicine of University of São Paulo. They were collected in caves of Salto do Pirapora and Salto de Itu Cities (State of São Paulo), Southeastern Brazil.

The air circulation in the interior of the cages occurred through an inlet and an outlet system with biosafety filters. The system was designed with consideration for the

Results

In the oral vaccination experiment, the proportion of bats that survived after challenge with 105 MICLD50, was 14% (Group A), 25% (Group B), 42% (Group C), 66% (Group D), and 100% (Group E). The incubation period ranged from 5 to 19 days (average 6.9 days) and the morbidity period was usually from 24 to 48 h (Table 1).

In the indirect vaccination experiment, the proportion of survivors was 42.8% (Group A), 71.4% (Group B), 57.1% (Group C), 57.1% (Group D), 71.4% (Group E), 62.5% (Group F), 55.5%

Discussion

We expected, as in the case of bat control by vampiricide paste, that the administration of V-RG vaccine through paste in one or two bats could induce immunity and so indirectly protect other bats from the same group. We think that our results are encouraging because a significant number of bats that did not receive the vaccine were indirectly immunized by contact and survived the virus challenge.

When administered directly into the mouth, the V-RG vaccine was immunogenic to hematophagous bats,

Acknowledgements

The following people provided volunteer field assistance to locating and capturing bats: Carlos Alberto Venésio Gomes from Vigilância Sanitária of Paraisópolis-Minas Gerais; Luis Carlos Ismerin and José Carlos Pinto from Escritório de Defesa Agropecuária of Sorocaba, São Paulo. We also thank Akio Sato, Cristiano Von Simson and Emílio Salani from Merial Saúde Animal Ltda. The following people provided administrative assistance: Vilma A Duarte Sanches, Valtair Santana and Ruberval da Silva from

References (32)

  • M. Ito et al.

    Genetic characterization and geographic distribution of rabies virus isolates in Brazil: identification of two reservoir, dogs and vampire bats

    Virology

    (2001)
  • A. Aguilar-Setien et al.

    Experimental rabies infection and oral vaccination in vampire bats (Desmodus rotundus)

    Vaccine

    (1998)
  • A. Aguilar-Setien et al.

    Vaccination of vampire bats using recombinant vaccinia-rabies virus

    J. Wildl. Dis.

    (2002)
  • Almeida, M.F., Martorelli, L.F.A., Aires, C.C., Sallum, P.C., Durigon, E.L., Massad, E., 2005. Experimental rabies...
  • C. Arellano-Sota

    Biology, ecology, and control of the vampire bat

    Rev. Infect. Dis.

    (1988)
  • G. Baer et al.

    A new method of bleeding small and infant bats

    J. Mammol.

    (1971)
  • M. Batista da Costa et al.

    An outbreak of vampire bats bite in the Brazilian village

    Trop. Med. Parasitol.

    (1993)
  • J. Blancou et al.

    Rage experimentale du renard roux (Vulpes vulpes) I.Sensibilite selon la voie d’infection et la dose infectante

    Rev. Med. Vet.

    (1979)
  • J. Blancou et al.

    Innocuite et efficacite d’un vaccin antirabique recombinant des virus de la vaccine et la rage administre par voie orale au renard, au chien et au chat

    Ann. Rech. Vet.

    (1989)
  • Brazil, Minister of Health from Brazil, 2004. Casos de raiva humana por espécie agressora, Brasil, 1986–2004, Casos...
  • B. Brochier et al.

    Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: Innocuity to several non-target bait-consuming species

    J. Wildl. Dis.

    (1989)
  • B. Brochier et al.

    Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

    Nature

    (1991)
  • CDC, 2000. Human Rabies-California, Georgia, Minnesota, New York and Wisconsin, MMWR 49 (49),...
  • D.G. Constantine

    Rabies transmission by non-bite route

    Publ. Health Rep.

    (1962)
  • D.G. Constantine

    Rabies transmission by air in bat caves

    Publ. Health Rep.

    (1967)
  • Dean, D.J., Abelseth, M.K., Atanasiu, P., 1996. The fluorescent antibody test, In: F.-X., Meslin, M.M., Kaplan, H.,...
  • Cited by (25)

    • Bat rabies

      2020, Rabies: Scientific Basis of the Disease and Its Management, Fourth Edition
    • Ebolavirus vaccines for humans and apes

      2012, Current Opinion in Virology
      Citation Excerpt :

      An alternative approach to human and ape vaccination would be to directly immunize species of fruit bats which are thought to be the reservoir for ebolavirus [46,47]. Because of the large size of the bat population, unconventional vaccine strategies such as the application of vaccine in a vaseline formulation on the back of carrier bats (Figure 1), as previously described for rabies immunization [48,49] could be implemented. Great apes are in danger of extermination mainly because of habitat loss, hunting, and infectious disease.

    • Evolution of Wildlife Rabies Control Tactics

      2011, Advances in Virus Research
      Citation Excerpt :

      V-RG (in Vaseline) was applied to the back of vampire bats in captivity to see if their behaviors would result in the immunization of other bats in the same containment area. V-RG proved to be immunogenic and survival of bats was good (43–71%) upon challenge with rabies virus (Almeida et al., 2005, 2008a,b). In the United States, Hanlon et al. (2002) evaluated an attenuated SAG2 rabies vaccine for safety and efficacy when administered orally to skunks and raccoons.

    • Detection of specific antibody responses to vaccination in variable flying foxes (Pteropus hypomelanus)

      2009, Comparative Immunology, Microbiology and Infectious Diseases
      Citation Excerpt :

      Bats are fastidious groomers, and vampire bats have been shown to take up anticoagulants applied to the backs of conspecifics [26]. Oral rabies vaccines have been shown to be effective against challenge in vampire bats [26,29,32]. Oral subunit vaccines delivered via transgenic plants have been suggested [31].

    View all citing articles on Scopus
    View full text